← Eichor
Study identifier: NCT07213154 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

Condition: Malignant Skin Neoplasm · Skin Disorder · Skin Neoplasm  ·  Sponsor: Emory University

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial studies how well an optical imaging scan called quantitative oblique back-illumination microscopy (qOBM) helps in diagnosing skin cancer in patients with skin lesions. qOBM is a non-invasive procedure that uses red light for illumination, and may work better than no imaging procedures in aiding doctors in diagnosing skin lesions.

This description comes directly from the study's public registry record.

Talk to the study team

Mohammad K. Khan, MD, PhD, MS, FACRO, FACR, DABR  ·  404-778-3473  ·  m.k.khan@emory.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Emory University Hospital MidtownAtlanta, Georgia, United StatesRecruiting
Emory University Hospital/Winship Cancer InstituteAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07213154